Pathophysiological mechanisms underlying increased anxiety after soman exposure: Reduced GABAergic inhibition in the basolateral amygdala

NeuroToxicology

Volumn 44, Issue , 2014, Pages 335-343

  Prager, Eric M ^a   Pidoplichko, Volodymyr I ^a   Aroniadou Anderjaska, Vassiliki ^a   Apland, James P ^b   Braga, Maria F M ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Alpha7 nicotinic receptors; Anxiety; Basolateral amygdala; GABA Inhibition; Soman

Indexed keywords

SOMAN; BUNGAROTOXIN RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR; CHEMICAL WARFARE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; BRAIN REGION; CELL LOSS; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; EPILEPTIC STATE; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; NERVE EXCITABILITY; NEUROMODULATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL TISSUE; CHOLINERGIC STIMULATION; GABAERGIC SYSTEM; NERVE CELL EXCITABILITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PATHOPHYSIOLOGY; SPONTANEOUS EXCITATORY POSTSYNAPTIC CURRENT; SPONTANEOUS INHIBITORY POSTSYNAPTIC CURRENT; SYNAPTIC INHIBITION; WHOLE CELL PATCH CLAMP; ANIMAL; ANXIETY; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANXIETY; BASOLATERAL NUCLEAR COMPLEX; CHEMICAL WARFARE AGENTS; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SOMAN; STATUS EPILEPTICUS; SYNAPTIC TRANSMISSION;

EID: 84907349851     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.08.007     Document Type: Article

References (68)

1. Apland J.P., Figueiredo T.H., Qashu F., Aroniadou-Anderjaska V., Souza A.P., Braga M.F. Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology. Neurotoxicology 2010, 31:485-492.
2. Aroniadou-Anderjaska V., Pidoplichko V.I., Figueiredo T.H., Almeida-Suhett C.P., Prager E.M., Braga M.F. Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors. Neuroscience 2012, 221:157-169.
3. Ben-Ari Y., Zigmond R.E., Shute C.C., Lewis P.R. Regional distribution of choline acetyltransferase and acetylcholinesterase within the amygdaloid complex and stria terminalis system. Brain Res 1977, 120:435-444.
4. Bencan Z., Levin E.D. The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiol Behav 2008, 95:408-412.
5. Braun P., Greenberg D., Dasberg H., Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990, 51:236-238.
6. Carpentier P., Testylier G., Dorandeu F., Segebarth C., Montigon O., Foquin A., et al. Hyperosmolar treatment of soman-induced brain lesions in mice: evaluation of the effects through diffusion-weighted magnetic resonance imaging and through histology. Toxicology 2008, 253:97-103.
7. Cates M.E., Bishop M.H., Davis L.L., Lowe J.S., Woolley T.W. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother 2004, 38:1395-1399.
8. Chen Y. Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology 2012, 33:391-400.
9. Collombet J.M., Pierard C., Beracochea D., Coubard S., Burckhart M.F., Four E., et al. Long-term consequences of soman poisoning in mice Part 1. Neuropathology and neuronal regeneration in the amygdala. Behav Brain Res 2008, 191:88-94.
10. Coubard S., Beracochea D., Collombet J.M., Philippin J.N., Krazem A., Liscia P., et al. Long-term consequences of soman poisoning in mice: part 2. Emotional behavior. Behav Brain Res 2008, 191:95-103.
11. Davidson J.R., Brady K., Mellman T.A., Stein M.B., Pollack M.H. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol 2007, 27:85-88.
12. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 1994, 17:208-214.
13. Dolgin E. Syrian gas attack reinforces need for better anti-sarin drugs. Nat Med 2013, 19:1194-1195.
14. Espana J., Gimenez-Llort L., Valero J., Minano A., Rabano A., Rodriguez-Alvarez J., et al. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry 2010, 67:513-521.
15. Etkin A., Wager T.D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007, 164:1476-1488.
16. Ferretti L., McCurry S.M., Logsdon R., Gibbons L., Teri L. Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol 2001, 14:52-58.
17. Feuerbach D., Lingenhoehl K., Olpe H.R., Vassout A., Gentsch C., Chaperon F., et al. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 2009, 56:254-263.
18. Figueiredo T.H., Qashu F., Apland J.P., Aroniadou-Anderjaska V., Souza A.P., Braga M.F. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. J Pharmacol Exp Ther 2011, 336:303-312.
19. Filliat P., Coubard S., Pierard C., Liscia P., Beracochea D., Four E., et al. Long-term behavioral consequences of soman poisoning in mice. Neurotoxicology 2007, 28:508-519.
20. Goodkin H.P., Joshi S., Mtchedlishvili Z., Brar J., Kapur J. Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J Neurosci 2008, 28:2527-2538.
21. Goodkin H.P., Yeh J.L., Kapur J. Status epilepticus increases the intracellular accumulation of GABAA receptors. J Neurosci 2005, 25:5511-5520.
22. Gullapalli R.P., Aracava Y., Zhuo J., Helal Neto E., Wang J., Makris G., et al. Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman. Neurotoxicology 2010, 31:67-76.
23. Hirsch J.C., Agassandian C., Merchan-Perez A., Ben-Ari Y., DeFelipe J., Esclapez M., et al. Deficit of quantal release of GABA in experimental models of temporal lobe epilepsy. Nat Neurosci 1999, 2:499-500.
24. Hoffman A., Eisenkraft A., Finkelstein A., Schein O., Rotman E., Dushnitsky T. A decade after the Tokyo sarin attack: a review of neurological follow-up of the victims. Mil Med 2007, 172:607-610.
25. Jimmerson V.R., Shih T.M., Mailman R.B. Variability in soman toxicity in the rat: correlation with biochemical and behavioral measures. Toxicology 1989, 57:241-254.
26. Klein R.C., Yakel J.L. Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex. J Physiol 2006, 576:865-872.
27. Koenigs M., Grafman J. Posttraumatic stress disorder: the role of medial prefrontal cortex and amygdala. Neuroscientist 2009, 15:540-548.
28. Lang E.J., Pare D. Similar inhibitory processes dominate the responses of cat lateral amygdaloid projection neurons to their various afferents. J Neurophysiol 1997, 77:341-352.
29. Lang E.J., Pare D. Synaptic responsiveness of interneurons of the cat lateral amygdaloid nucleus. Neuroscience 1998, 83:877-889.
30. Langston J.L., Wright L.K., Connis N., Lumley L.A. Characterizing the behavioral effects of nerve agent-induced seizure activity in rats: increased startle reactivity and perseverative behavior. Pharmacol Biochem Behav 2012, 100:382-391.
31. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 2003, 23:727-738.
32. Martinowich K., Schloesser R.J., Lu Y., Jimenez D.V., Paredes D., Greene J.S., et al. Roles of p75(NTR), long-term depression, and cholinergic transmission in anxiety and acute stress coping. Biol Psychiatry 2012, 71:75-83.
33. McDonald A.J., Mascagni F. Immunohistochemical characterization of somatostatin containing interneurons in the rat basolateral amygdala. Brain Res 2002, 943:237-244.
34. McDonough J.H., Dochterman L.W., Smith C.D., Shih T.M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 16:123-132.
35. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997, 21:559-579.
36. Mesulam M.M., Hersh L.B., Mash D.C., Geula C. Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study. J Comp Neurol 1992, 318:316-328.
37. Moffett M.C., Schultz M.K., Schwartz J.E., Stone M.F., Lumley L.A. Impaired auditory and contextual fear conditioning in soman-exposed rats. Pharmacol Biochem Behav 2011, 98:120-129.
38. Myhrer T. Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment. Neurotoxicology 2010, 31:629-638.
39. Naylor D.E. Glutamate and GABA in the balance: convergent pathways sustain seizures during status epilepticus. Epilepsia 2010, 51(Suppl 3):106-109.
40. Naylor D.E., Liu H., Wasterlain C.G. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005, 25:7724-7733.
41. Ohtani T., Iwanami A., Kasai K., Yamasue H., Kato T., Sasaki T., et al. Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study. Psychiatry Clin Neurosci 2004, 58:624-629.
42. Pan B.X., Dong Y., Ito W., Yanagawa Y., Shigemoto R., Morozov A. Selective gating of glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAb receptor. Neuron 2009, 61:917-929.
43. Park K., Lee S., Kang S.J., Choi S., Shin K.S. Hyperpolarization-activated currents control the excitability of principal neurons in the basolateral amygdala. Biochem Biophys Res Commun 2007, 361:718-724.
44. Pavlov I., Huusko N., Drexel M., Kirchmair E., Sperk G., Pitkanen A., et al. Progressive loss of phasic, but not tonic, GABAA receptor-mediated inhibition in dentate granule cells in a model of post-traumatic epilepsy in rats. Neuroscience 2011, 194:208-219.
45. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
46. Pidoplichko V.I., Prager E.M., Aroniadou-Anderjaska V., Braga M.F. alpha7-containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability. J Neurophysiol 2013, 110:2358-2369.
47. Popescu A.T., Pare D. Synaptic interactions underlying synchronized inhibition in the basal amygdala: evidence for existence of two types of projection cells. J Neurophysiol 2011, 105:687-696.
48. Prager E.M., Aroniadou-Anderjaska V., Almeida-Suhett C.P., Figueiredo T.H., Apland J.P., Braga M.F. Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure. Neurotoxicology 2013, 38:84-90.
49. Prager E.M., Aroniadou-Anderjaska V., Almeida-Suhett C.P., Figueiredo T.H., Apland J.P., Rossetti F., et al. The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: Relation to anxiety-like behavior. Neuropharmacology 2014, 81C:64-74.
50. Prager E.M., Bergstrom H.C., Grunberg N.E., Johnson L.R. The importance of reporting housing and husbandry in rat research. Front Behav Neurosci 2011, 5:38.
51. Racine R., Rose P.A., Burnham W.M. After discharge thresholds and kindling rates in dorsal and ventral hippocampus and dentate gyrus. Can J Neurol Sci 1977, 4:273-278.
52. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
53. Rauch S.L., Shin L.M., Phelps E.A. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biol Psychiatry 2006, 60:376-382.
54. Rauch S.L., Whalen P.J., Shin L.M., McInerney S.C., Macklin M.L., Lasko N.B., et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000, 47:769-776.
55. Ravindran L.N., Stein M.B. Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Res 2009, 1293:24-39.
56. Rogers M.A., Yamasue H., Abe O., Yamada H., Ohtani T., Iwanami A., et al. Smaller amygdala volume and reduced anterior cingulate gray matter density associated with history of post-traumatic stress disorder. Psychiatry Res 2009, 174:210-216.
57. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
58. Shekhar A., Truitt W., Rainnie D., Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 2005, 8:209-219.
59. Shih T.M., Duniho S.M., McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188:69-80.
60. Smith Y., Pare J.F., Pare D. Cat intraamygdaloid inhibitory network: ultrastructural organization of parvalbumin-immunoreactive elements. J Comp Neurol 1998, 391:164-179.
61. Spampanato J., Polepalli J., Sah P. Interneurons in the basolateral amygdala. Neuropharmacology 2011, 60:765-773.
62. Stein M.B., Stein D.J. Social anxiety disorder. Lancet 2008, 371:1115-1125.
63. Truitt W.A., Johnson P.L., Dietrich A.D., Fitz S.D., Shekhar A. Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala. Neuroscience 2009, 160:284-294.
64. Villarreal G., King C.Y. Brain imaging in posttraumatic stress disorder. Semin Clin Neuropsychiatry 2001, 6:131-145.
65. Wang Y., Liu L., Weiss T., Stewart C., Mikler J. Effect of acute soman exposure on GABA(A) receptors in rat hippocampal slices and cultured hippocampal neurons. Neurotox Res 2011, 20:343-350.
66. Woodruff A.R., Sah P. Inhibition and synchronization of basal amygdala principal neuron spiking by parvalbumin-positive interneurons. J Neurophysiol 2007, 98:2956-2961.
67. Yanagisawa N., Morita H., Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci 2006, 249:76-85.
68. Yu J., Proddutur A., Elgammal F.S., Ito T., Santhakumar V. Status epilepticus enhances tonic GABA currents and depolarizes GABA reversal potential in dentate fast-spiking basket cells. J Neurophysiol 2013, 109:1746-1763.